祖先基因组功能差异在寡头质:对阿尔茨海默氏症疾病的影响
Aura M Ramirez1, Luciana Bertholim Nasciben1, Sofia Moura1
1John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|September 12, 2025
概括
阿尔茨海默氏症的研究现在包括多样化的祖先,揭示APOE ε4载体改变了胆固醇代谢,并减少了寡基质中的髓化标志物. 这项研究验证了一种诱导多能干细胞 (iPSC) 模型,用于探索祖先特异性阿尔茨海默氏病 (AD) 机制.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 干细胞生物学 干细胞生物学
背景情况:
- 阿尔茨海默病 (AD) 研究历史上缺乏多样性,限制了对祖先特定机制的理解.
- 对大脑功能至关重要的寡头质细胞在AD病变发生过程中发挥作用.
- 诱导多能干细胞 (iPSCs) 提供了一个研究人类细胞功能和疾病的模型.
研究的目的:
- 研究患有阿尔茨海默氏病 (AD) 个体的iPSC衍生小基因组中的祖先特异性基因组调节.
- 通过包括非洲,美洲印第安人和欧洲祖先来解决多样性差距.
- 分析阿波利波蛋白E (APOE) 基因型对AD. oligodendroglia的影响.
主要方法:
- 从阿尔茨海默氏症患者和对照人群中生成了12个iPSC系,跨越了三种祖先,具有APOE ε3/ε3和APOE ε4/ε4基因型.
- 差异化的iPSCs变成神经球体,其中含有寡干细胞血统细胞.
- 利用单核RNA测序,ATAC-seq和Hi-C进行全面的基因组分析.
主要成果:
- 鉴定了AD候选基因的基因表达和染色质可访问性的祖先特异性差异.
- 在跨祖先的APOE ε4 / ε4载体中观察到上调的胆固醇生物合成和减少的髓化标志物.
- 对人类大脑转录组 (R2 > 0.85) 进行了验证的iPSC衍生的寡类细胞.
结论:
- 突出了AD研究中对多样化的祖先的关键需求.
- 表明早期APOE ε4对寡头质胆固醇代谢的影响.
- 建立了一个经过验证的iPSC模型,用于研究祖先特定的AD机制.
关键词:
APOE ε4 / ε4 基因型的基因型ATAC 测序的测序方法阿尔茨海默病 (AD) 是一种疾病.有关RNA测序的RNA测序祖先特定法规的规定.胆固醇的生物合成染色质可访问性 染色质可访问性诱导多能干细胞 (iPSCs) 是一种骨髓化 骨髓化类质细胞 (Oligodendrocytes) 是一种有机细胞.更多相关视频
10:53Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
5.5K
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
1.3K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Human Genetics
1.5K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.5K
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Glial Cells
93.2K
Overview
93.2K
